PTEN and adenocarcinoma: Based on this finding, we proceeded to delete one or both alleles of Survivin in the Pten deletion model, and through analyses of these new strains we provide direct genetic evidence that loss of survivin expression in the prostate epithelium strongly inhibits the progression of prostatic premalignant lesions to adenocarcinoma in these animals.